Share on StockTwits

CVS Caremark (NYSE:CVS) shares saw unusually-strong trading volume on Wednesday following a stronger than expected earnings report, Stock Ratings Network reports. Approximately 6,945,077 shares traded hands during trading, an increase of 72% from the previous session’s volume of 4,041,359 shares.The stock last traded at $77.28 and had previously closed at $77.27.

The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter in the previous year, the company posted $0.97 earnings per share. The company’s revenue for the quarter was up 10.7% on a year-over-year basis.

CVS has been the subject of a number of recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of CVS Caremark in a research note on Wednesday. They now have a $91.00 price target on the stock, up previously from $82.00. Separately, analysts at Cantor Fitzgerald raised their price target on shares of CVS Caremark from $66.00 to $71.00 in a research note on Wednesday. Finally, analysts at Morgan Stanley raised their price target on shares of CVS Caremark from $81.00 to $85.00 in a research note on Wednesday. One analyst has rated the stock with a sell rating, three have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $80.48.

The stock’s 50-day moving average is $76.91 and its 200-day moving average is $74.23. The company has a market cap of $90.356 billion and a P/E ratio of 19.68. CVS Caremark also was the target of unusually large options trading on Monday. Traders purchased 7,359 put options on the company. This is an increase of approximately 776% compared to the typical daily volume of 840 put options.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.